and adjusted and gaap earnings per share decreased num-one% and num-two% over prior year to $num-three and $num-four, respectively.
our guidance for adjusted and gaap earnings per share range from $num-one to $num-two and $num-three to $num-four, respectively.
our guidance for adjusted and gaap earnings per share range from $num-one to $num-two and $num-three to $num-four, respectively.
our guidance for adjusted and gaap earnings per share range from $num-one to $num-two and $num-three to $num-four, respectively.
third quarter sales increased num-one% over prior year to $num-two billion, with foreign exchange rates accounting for num-three basis points of the quarter's growth.
and adjusted and gaap earnings per share decreased num-one% and num-two% over prior year to $num-three and $num-four, respectively.
our guidance for adjusted and gaap earnings per share range from $num-one to $num-two and $num-three to $num-four, respectively.
for the fourth quarter, we expect total sales of $num-one billion to $num-two billion, which, at the midpoint, implies a num-three% decline over prior year.
and our guidance for full year year-five operating cash flow is $num-one million to $num-two million, which includes the impact from the higher-than-anticipated ppe inventory.
while we now expect to end the year with higher-than-anticipated ppe inventory, we continue to expect to generate positive operating cash flow in the second half and for the full year.
and adjusted and gaap earnings per share decreased num-one% and num-two% over prior year to $num-three and $num-four, respectively.